Global Neurology Academy

Optimizing Vitamin D Supplementation in MS Care
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiers
Optimizing Vitamin D Supplementation in MS Care
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiers
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiers
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
- Jerome Lisk, MD, MBA, M.S., FAAN
- Michael Salvatore, PhD
- Vicki Nejtek-Salvatore, PhD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
- Charles Turck, PharmD, BCPS, BCCCP
- Tushita Mayanil, MBBS (MD)
- Melanie Yabs, PharmD, MS, BCPP
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiers
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
- Ashley Baker, MSN, PMHNP
- Stephen Marder, MD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
- Jeffrey A. Lieberman, MD

Medical News

Medical News
Phase 3 RESILIENT Trial: Tonmya's Role in Non-Opioid Pain Management
02/02/2026
Read more
Medical News
Advancements in Lab-Grown Corticospinal Neurons for ALS and Spinal Injury Research
02/02/2026
Read more
Medical News
Transcranial Direct Current Stimulation: Evaluating Clinical Implications for Depression and Anxiety
02/02/2026
Read more
Medical News
COMFORT Trial: Peripheral Nerve Stimulation Provides Durable Pain Relief
02/02/2026
Read more

See more news

CME/CE

CME/CE In-Person Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
Boston, Massachusetts
1.00 credit Learn more
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
CME/CE
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
1.00 credit
- Emily D. Clark, DO
- Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
- Susan Scanland, MSN, CRNP, GNP-BC, CDP
- Anthony J. Viera, MD, MPH
1.00 credit
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CE
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
1.00 credit
- Stephen Chrzanowski, MD, PhD
- Aravindhan Veerapandiyan, MD
1.00 credit
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits

Clinical Practice

CME/CE In-Person Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
March 23, 2026
Boston, Massachusetts
1.00 credit Learn more
Evaluating Structured Interventions for Cognitive Support in MS
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstracts
Evaluating Structured Interventions for Cognitive Support in MS
- Hallie Blevins, PhD
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiers
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
- Alexandria May, PharmD, BCPS
- Michael Halassa, MD, PhD
Identifying and Managing Violence Risk in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
Global Neurology Academy
Identifying and Managing Violence Risk in Schizophrenia Care
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS

Programs

The Role of Neurofilament Light Chain in MS Management
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiers
The Role of Neurofilament Light Chain in MS Management
How Muscarinic Therapies Are Redefining Schizophrenia Care
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiers
How Muscarinic Therapies Are Redefining Schizophrenia Care
- Michael Halassa, MD, PhD
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Brown, MD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
- Alexandria May, PharmD, BCPS
- Nicholas Whipple, MD, MPH